Updates on Current and Pending Hypothalamic Obesity Clinical Trials
We are pleased to share updates on several clinical trials focusing on hypothalamic obesity (HO), ... Read more
The Raymond A. Wood Foundation and NORD® Launch Natural History Study of Rare Hypothalamic-Pituitary Brain tumors.
Research study is open to participants worldwide to advance understanding and treatments these rare diseases ... Read more
Illuminating Insights: Sharing a Recent Commentary on Our Research
The Raymond A. Wood Foundation is honored to share a significant development in our journey ... Read more
Clinical Trial Participant Best Practices
As a Participant, it’s Important to Do Your Part to Maintain the Integrity of the ... Read more
Innovating in Diabetes Insipidus Management: A Breakthrough in Blood Sodium Testing
Introduction Managing diabetes insipidus just got a significant boost, thanks to the groundbreaking work of ... Read more
Raymond A. Wood Foundation Reveals Caregiver Burden in Pioneering Craniopharyngioma Study
The Raymond A. Wood Foundation recently published its first research study entitled “Caregiver burden and ... Read more
Development of Patient Registry Well Underway
The Raymond A. Wood Foundation hosted our first International Hypothalamic-Pituitary Brain Tumor Patient Registry advisory ... Read more
Working to Develop a Sodium Meter for DI Patients
The Raymond A. Wood Foundation (RAWF) entered an agreement with Giner Labs, a world-renowned center ... Read more
2022 Research Progress on Craniopharyngioma
by Nathalie Kayadjanian, Ph.D., RAWF Scientific Advisor Image Credit: National Cancer Institute While surgery and ... Read more
Raymond A. Wood Foundation Joins the Children’s Brain Tumor Network Executive Council
The Children’s Brain Tumor Network (CBTN) is dedicated to driving innovative discovery, pioneering new treatments and accelerating open science to improve health for all children and young adults diagnosed with a brain tumor. The CBTN is the largest pediatric brain tumor biorepository and is made up of over 40 partner foundations. This month, Raymond A. Wood Foundation (RAWF) joined those partner organizations and has pledged $50,000 in support of the growth of CBTN’s craniopharyngioma biobank to accelerate research on tumor treatment and post-treatment management.
